IDAC Theranostics Competitors and Similar CompaniesClear all
Takeda's competitors and similar companies include CureVac and Biocon.
 Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | |||
Founding Date | Founding Date 1781 | Founding Date 2000 | Founding Date 1978 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | |
Employees | Employees 47,4554% decrease | Employees 82517% decrease | Employees 16,5612% increase |
Valuation ($) | Valuation ($) 43.7 b | Valuation ($) 648.3 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) ₹167.8b (FY, 2026) |
Cost of goods | Cost of goods ¥818.8b (FY, 2025) | Cost of goods €9.7m (FY, 2024) | Cost of goods ₹56.9b (FY, 2026) |
Gross profit | Gross profit ¥3.8t (FY, 2025) | Gross profit €534.4m (FY, 2024) | Gross profit ₹115.8b (FY, 2026) |
Net income | Net income ¥108.1b (FY, 2025) | Net income €162.2m (FY, 2024) | Net income ₹3.7b (FY, 2026) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 2 (May, 2025) | Phase I Trials Products 3 (May, 2020) | Phase I Trials Products N/A |
Funding | |||
Total funding raised | Total funding raised $ 57.8m | Total funding raised $ 1.1b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View company